2,4-Dinitrophenol (DNP): A Weight Loss Agent with Significant Acute Toxicity and Risk of Death
Johann Grundlingh,Paul I. Dargan,Paul I. Dargan,Marwa El-Zanfaly,David M. Wood,David M. Wood +5 more
TLDR
The pattern and pathophysiology of DNP toxicity is described, the previous fatalities associated with exposure to DNP are summarised and the current and previous fatalities related to exposure are summarized.Abstract:
2,4-Dinitrophenol (DNP) is reported to cause rapid loss of weight, but unfortunately is associated with an unacceptably high rate of significant adverse effects. DNP is sold mostly over the internet under a number of different names as a weight loss/slimming aid. It causes uncoupling of oxidative phosphorylation; the classic symptom complex associated with toxicity of phenol-based products such as DNP is a combination of hyperthermia, tachycardia, diaphoresis and tachypnoea, eventually leading to death. Fatalities related to exposure to DNP have been reported since the turn of the twentieth century. To date, there have been 62 published deaths in the medical literature attributed to DNP. In this review, we will describe the pattern and pathophysiology of DNP toxicity and summarise the previous fatalities associated with exposure to DNP.read more
Citations
More filters
Journal ArticleDOI
A New Era in Brown Adipose Tissue Biology: Molecular Control of Brown Fat Development and Energy Homeostasis
Shingo Kajimura,Masayuki Saito +1 more
TL;DR: The next challenge will be to develop strategies for activating BAT thermogenesis in adult humans to increase whole-body energy expenditure.
Journal ArticleDOI
Metformin directly acts on mitochondria to alter cellular bioenergetics
TL;DR: It is demonstrated that metformin directly acts on mitochondria to limit respiration and that the sensitivity of cells to meetformin is dependent on their ability to cope with energetic stress.
Journal ArticleDOI
Current pharmacotherapy for obesity.
TL;DR: A future direction of obesity pharmacotherapy research might include the potential for personalized medicine to target early responders to these anti-obesity drugs, as most of these drugs have a mean percentage weight loss reported in clinical trials but individual variations in response rates.
Journal ArticleDOI
Novel psychoactive substances of interest for psychiatry.
Fabrizio Schifano,Laura Orsolini,Laura Orsolini,G Duccio Papanti,G Duccio Papanti,John Corkery +5 more
TL;DR: In this article, the authors provide psychiatrists with updated knowledge of the clinical pharmacology and psychopathological consequences of the use of synthetic cannabinoids, including dopamine, CB1, GABA-A/B, 5-HT2A, glutamate, and k opioid receptors.
References
More filters
Book
Medical toxicology: Diagnosis and treatment of human poisoning
TL;DR: The general approach to the Poisoned Patient Introduction and Initial Evaluation and Supportive Care.
Book
Clinical management of poisoning and drug overdose
TL;DR: Part I: General Introduction: Emergency Management of Poisoning, Pediatric Resuscitation and Fluid Management, Laboratory Diagnosis and Drug Screening and Principles of Pharmacology for the Clinician.
Journal ArticleDOI
Mitochondrial targets of drug toxicity.
TL;DR: The significance is further underscored by the recent identification of bioenergetic control points for cell replication and differentiation and the realization that mitochondria play a determinant role in cell signaling and apoptotic modes of cell death.
Journal ArticleDOI
Mitochondrial uncoupling as a target for drug development for the treatment of obesity.
TL;DR: Mitochondrial proton cycling is responsible for a significant proportion of basal or standard metabolic rate, so further uncoupling of mitochondria may be a good way to increase energy expenditure and represents a good pharmacological target for the treatment of obesity.